Selected article for: "accurate assessment and additional assessment"

Author: Jianghong An; Xuejiao Liao; Tongyang Xiao; Shen Qian; Jing Yuan; Haocheng Ye; Furong Qi; Chengguang Shen; Yang Liu; Lifei Wang; Xiaoya Cheng; Na Li; Qingxian Cai; Fang Wang; Jun Chen; Yingxia Liu; Yunfang Wang; Feng Zhang; Yang Fu; Xiaohua Tan; Lei Liu; Zheng Zhang
Title: Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test
  • Document date: 2020_3_30
  • ID: 58sc6xgq_53
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 26.20044222 doi: medRxiv preprint tests. However, hyper-sensitive detection methods revealed the existence of SARS-CoV-2 RNA in RP patient specimens tested to be negative using the commercial kit. Therefore, it is necessary to develop a more accurate quantitative assessment of the RNA dynamics and additional discharge criteria to help physic.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 26.20044222 doi: medRxiv preprint tests. However, hyper-sensitive detection methods revealed the existence of SARS-CoV-2 RNA in RP patient specimens tested to be negative using the commercial kit. Therefore, it is necessary to develop a more accurate quantitative assessment of the RNA dynamics and additional discharge criteria to help physicians make a decision. This study provided valuable empirical information and clinical evidence support for effective management of COVID-19 patients during convalescent period. Further study should evaluate the potential clinical significance and transmission risk of RP patients.

    Search related documents:
    Co phrase search for related documents
    • clinical evidence and detection method: 1
    • clinical evidence and effective management: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical evidence and physician decision: 1, 2
    • clinical evidence and quantitative assessment: 1, 2, 3, 4, 5
    • clinical significance and commercial kit: 1
    • clinical significance and detection method: 1, 2, 3, 4, 5, 6
    • clinical significance and effective management: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical significance and empirical information: 1, 2, 3, 4
    • clinical significance and physician decision: 1, 2
    • clinical significance and potential clinical significance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical significance and quantitative assessment: 1, 2
    • commercial kit and detection method: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • commercial kit and effective management: 1, 2
    • commercial kit and empirical information: 1
    • commercial kit and hyper sensitive detection method: 1, 2
    • commercial kit and potential clinical significance: 1
    • detection method and effective management: 1, 2, 3, 4, 5
    • detection method and hyper sensitive detection method: 1, 2
    • detection method and patient effective management: 1